Medication info
Dabidueo Tablet 10/10 mg (Ezetimibe, Rosuvastatin Calcium)

Dabidueo Tablet 10/10 mg (Ezetimibe, Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Nokzibja Co., Ltd.
Appearance
White to almost white round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201601226 · Approved 2016.02.29 · Insurance code 643605170

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Ingredients

Manufacturer
Nokzibja Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps to control blood lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, it is used to lower total cholesterol, LDL-cholesterol, apo B protein, triglycerides, and non-HDL-cholesterol levels, while raising HDL-cholesterol levels to reduce the risk of cardiovascular disease. This medication is used in conjunction with a diet and is administered as an adjunct when dietary control alone is insufficient. Before treatment, other causes of dyslipidemia, such as diabetes and hypothyroidism, should be identified and treated if necessary. Additionally, regular lipid level monitoring is recommended, especially assessing lipid levels from the initial hospitalization of patients with acute coronary incidents. In summary, this medication is used to improve blood lipids in patients with hypercholesterolemia and dyslipidemia to reduce the risk of atherosclerotic vascular disease.

How to take

Adult dose

This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Precautions

This medication may cause serious muscle problems, so it should be temporarily discontinued or stopped if acute serious myopathy appears or there is a risk of kidney dysfunction due to rhabdomyolysis. This medication should not be used in patients with allergies to the active substance or components, patients with liver function issues or active liver disease, patients with muscle disorders, patients taking certain immunosuppressants, patients with severe kidney dysfunction, pregnant women or women who may become pregnant, and nursing mothers. Patients at high risk for myopathy or rhabdomyolysis, patients with liver function impairment, elderly patients, alcoholics, and those taking certain medications should use this medication with caution and require regular testing as per doctor's instructions. While taking this medication, patients should immediately report any symptoms such as muscle pain, muscle cramps, muscle weakness, fatigue, fever, etc. to their doctor, and treatment may be stopped in severe cases. Liver function tests should be conducted before and during treatment, as abnormal liver function may occur; if liver enzyme levels remain elevated, dose adjustment or discontinuation may be necessary. This medication can be harmful to the fetus during pregnancy, so women who are pregnant or planning to become pregnant must consult with a doctor and employ appropriate contraception. Safety and efficacy in children and adolescents have not been adequately established, so administration is not recommended. Elderly patients are at higher risk for myopathy, so caution is warranted, but special dose adjustments are generally not necessary. Patients with impaired kidney function should be closely monitored due to the risk of muscle issues. This medication can interact with other drugs, so patients taking anticoagulants, fibrate-class medications, certain antibiotics, and antifungals should inform their physician. In case of overdose, there is no specific antidote; symptomatic treatment and appropriate supportive therapy are required, and monitoring of liver function and muscle enzyme levels should be performed. This medication must be kept out of the reach of children, and transferring to another container is not recommended.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevation of ALT, elevation of AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, unusual sensation, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, fatty liver, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory difficulties, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, weakness, angioedema, increased blood glucose, abdominal pain, diarrhea, fatigue, numbness, dysesthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, myalgia, joint pain, increased CK, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival hyperemia, renal failure, liver function abnormalities, increased serum creatinine, elevated blood pressure, increased serum urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White to almost white round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.